A project from the American Society of Retina SpecialistsSign in to view content
Interim Subretinal Gene Therapy Safety Results in Two Phase 1/2 Open-label, Dose-Escalation Clinical Trials to Treat Achromatopsia
- Video
- Published 2022
Related
Category: Imaging - Digital - Angiography